CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Yahoo Finance07:00

Press Release: CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Dow JonesJan 7 21:01

BofA Securities Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Cuts Target Price to $85

Futu NewsJan 7 20:36 · Ratings

Cathie Wood's ARK Innovation ETF Couldn't Keep Up in 2024

BarronsJan 7 14:30

CRISPR Therapeutics AG's (NASDAQ:CRSP) Recent 4.5% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures

Simply Wall StDec 31, 2024 21:31

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

Yahoo FinanceDec 29, 2024 19:36